Published On : August 2017 Pages : 97 Category: Healthcare IT Report Code : HC06118
Industry Trend Analysis
The global teleradiology market is expected to be around $10 billion by 2027. This can be primarily attributed to number of factors such as increasing incidence of chronic diseases, growing number of emergency cases, increase in number of diagnostic imaging scans, and implementation of picture archiving and communication system (PACS). In addition to this, ongoing improvements in telecommunication and imaging modalities will further trigger the demand for tele-diagnosis, tele-consultation, and tele-monitoring. Moreover, the instant remote access to the images on the cloud network facilitates radiologists to efficiently diagnose, consult, and monitor the patient at remote locations. However, the lack of data security will hinder the market growth during the forecast period.
Modality Outlook and Trend Analysis
On the basis of modality, the market is classified into X-ray, magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and nuclear radiology.
Among these, X-ray segment held major share of the global teleradiology market in 2017. This segment is projected to dominate the market throughout the forecast period. This large market share can be attributed to a number of factors such as the growing number of X-ray scans due to increasing number of bone related fractures and dental injuries. Moreover, development of technologically advanced filmless X-ray systems will further contribute to the market growth.
Computed tomography market is projected to be the fastest growing segment during the forecast period as this is one of the most widely adopted imaging modality due to its high resolution imaging capacity. Additionally, launch of new generation CT models will further drive the growth of the market.
Ultrasound is one of the most popular diagnostic imaging modality. It is the most widely used imaging technique for observing the fetus during pregnancy. It is also used in the detection of other medical ailments in women. The market for ultrasound segment is primarily driven by factors such as development of 3D and 4D ultrasound systems and associated advantages such as the portability, minimal invasive, cost effective and low radiation risk.
Regional Outlook and Trend Analysis
North America accounted for the largest share of the global teleradiology market in 2017. This large share is primarily attributed to number of factors such as the availability of high speed internet services in the region, high adoption rate of technologically advanced products, and presence of developed infrastructure along with high healthcare expenditure.
The Asia-Pacific teleradiology market is projected to exhibit significant growth during the forecast period due to huge patient population and increasing healthcare expenditure in countries such as China and India. In addition to this, the growing demand for advanced medical platforms will further contribute to the market growth.
Competitive Insights
The key players in the teleradiology market emphasize on strategic expansion through collaborations, mergers and acquisitions to increase their presence in the global market. For instance, in October 2017, ARIS Radiology, acquired US Teleradiology, an Atlanta based teleradiology company, to provide an extended range of radiology services and staffing solutions to medical facilities.
Some of the major players in the teleradiology market are Virtual Radiologic Corporation (an affiliate of MEDNAX Inc.), Agfa-Gevaert N.V., ONRAD, Inc., Everlight Radiology Pty Ltd, Cybernet Systems Corporation, RamSoft, Inc., Spectra AB, StatRad, LLC. and USARAD Holdings, Inc.
Teleradiology Market Segmentation:
By Modality:
By Region:
Some of the key questions answered by the report are:
Market Classification
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Increase in Number of Diagnostic Imaging Scans
3.2.1.2. Growing Number of Emergency Cases
3.2.1.3. Implementation of Picture Archiving and Communication System (PACS)
3.2.2. Restraints
3.2.2.1. Lack of Data Security
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Teleradiology Market, By Modality
4.1. Introduction
4.2. Teleradiology Market Assessment and Forecast, By Modality, 2017-2027
4.3. X-ray
4.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4. Magnetic Resonance Imaging (MRI)
4.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.5. Computed Tomography (CT)
4.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.6. Ultrasound
4.6.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.7. Nuclear Radiology
4.7.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5. Teleradiology Market, By Region
5.1. Introduction
5.2. Teleradiology Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.3. North America
5.3.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
5.3.2. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.3.2.1. U.S.
5.3.2.1.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.3.2.2. Canada
5.3.2.2.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.3.2.3. Mexico
5.3.2.3.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.4. Europe
5.4.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
5.4.2. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.4.2.1. Germany
5.4.2.1.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.4.2.2. France
5.4.2.2.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.4.2.3. UK
5.4.2.3.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.4.2.4. Italy
5.4.2.4.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.4.2.5. Spain
5.4.2.5.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.4.2.6. Russia
5.4.2.6.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.4.2.7. Rest of Europe
5.4.2.7.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.5. Asia-Pacific
5.5.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
5.5.2. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.5.2.1. Japan
5.5.2.1.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.5.2.2. China
5.5.2.2.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.5.2.3. Australia
5.5.2.3.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.5.2.4. India
5.5.2.4.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.5.2.5. South Korea
5.5.2.5.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.5.2.6. Rest of Asia-Pacific
5.5.2.6.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.6. Rest of the World
5.6.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
5.6.2. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.6.2.1. Brazil
5.6.2.1.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.6.2.2. Turkey
5.6.2.2.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.6.2.3. Saudi Arabia
5.6.2.3.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.6.2.4. South Africa
5.6.2.4.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.6.2.5. United Arab Emirates
5.6.2.5.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
5.6.2.6. Others
5.6.2.6.1. Market Assessment and Forecast, By Modality, 2017-2027 ($Million)
6. Company Profiles
6.1. Virtual Radiologic Corporation (an affiliate of MEDNAX Inc.)
6.1.1. Business Overview
6.1.2. Product Portfolio
6.1.3. Key Financials
6.1.4. Strategic Developments
6.2. Agfa-Gevaert N.V.
6.2.1. Business Overview
6.2.2. Product Portfolio
6.2.3. Key Financials
6.2.4. Strategic Developments
6.3. ONRAD, Inc.
6.3.1. Business Overview
6.3.2. Product Portfolio
6.3.3. Strategic Developments
6.4. Everlight Radiology Pty Ltd
6.4.1. Business Overview
6.4.2. Product Portfolio
6.4.3. Strategic Developments
6.5. Cybernet Systems Corporation
6.5.1. Business Overview
6.5.2. Product Portfolio
6.5.3. Strategic Developments
6.6. RamSoft, Inc.
6.6.1. Business Overview
6.6.2. Product Portfolio
6.6.3. Strategic Developments
6.7. Spectra AB
6.7.1. Business Overview
6.7.2. Product Portfolio
6.7.3. Strategic Developments
6.8. StatRad, LLC.
6.8.1. Business Overview
6.8.2. Product Portfolio
6.8.3. Strategic Developments
6.9. USARAD Holdings, Inc.
6.9.1. Business Overview
6.9.2. Product Portfolio
6.9.3. Strategic Developments
List of Tables
Table 1.Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 2.X-ray Market, By Region, 2017-2025 ($Million)
Table 3.Magnetic Resonance Imaging Market, By Region, 2017-2025 ($Million)
Table 4.Computed Tomography Market, By Region, 2017-2025 ($Million)
Table 5.Ultrasound Market, By Region, 2017-2025 ($Million)
Table 6.Nuclear Radiology Market, By Region, 2017-2025 ($Million)
Table 7.Teleradiology Market, By Region, 2017-2025 ($Million)
Table 8.NorthAmerica Teleradiology Market, By Country, 2017-2025 ($Million)
Table 9.North America Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 10.U.S. Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 11.Canada Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 12.Mexico Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 13.Europe Teleradiology Market, By Country, 2017-2025 ($Million)
Table 14.Europe Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 15.Germany Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 16.France Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 17.UK Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 18.Italy Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 19.Spain Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 20.Russia Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 21.Rest of Europe Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 22.Asia-Pacific Diabetes Devices Market, By Country, 2017-2025 ($Million)
Table 23.Asia-Pacific Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 24.Japan Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 25.China Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 26.Australia Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 27.India Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 28.South Korea Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 29.Rest of Asia-Pacific Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 30.Rest of the World Teleradiology Market, By Country, 2017-2025 ($Million)
Table 31.Rest of the World Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 32.Brazil Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 33.Turkey Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 34.Saudi Arabia Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 35.South Africa Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 36.United Arab Emirates Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 37.Other Teleradiology Market, By Modality, 2017-2025 ($Million)
Table 38.Virtual Radiologic Corporation: Key Strategic Developments, 2017-2017
Table 39.Agfa-Gevaert N.V.: Key Strategic Developments, 2017-2017
Table 40.ONRAD, Inc.: Key Strategic Developments, 2017-2017
Table 41.Everlight Radiology Pty Ltd: Key Strategic Developments, 2017-2017
Table 42.Cybernet Systems Corporation: Key Strategic Developments, 2017-2017
Table 43.RamSoft, Inc.: Key Strategic Developments, 2017-2017
Table 44.Spectra AB: Key Strategic Developments, 2017-2017
Table 45.StatRad, LLC.: Key Strategic Developments, 2017-2017
Table 46.USARAD Holdings, Inc.: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Teleradiology Market, By Modality, 2017 & 2025 ($Million)
Figure 3.Teleradiology Market, By Region, 2017 & 2025 ($Million)
Figure 4.MEDNAX Inc.: Net Revenues, 2017-2017 ($Million)
Figure 5.MEDNAX Inc.: Net Revenue Share, By Segment, 2017
Figure 6.MEDNAX Inc.: Net Revenue Share, By Geography, 2017
Figure 7.Agfa-Gevaert N.V.: Net Revenues, 2017-2017 ($Million)
Figure 8.Agfa-Gevaert N.V.: Net Revenue Share, By Segment, 2017
Figure 9.Agfa-Gevaert N.V.: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
Data Collection Matrix |
Supply Side |
Demand Side |
Primary Data Sources |
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
Qualitative Data |
Quantitative Data (2017-2025) |
|
|